LabCast: Simple and fast top-down protein characterization using neofleX benchtop MALDI-TOF/TOF
Overview
MALDI Top-Down Sequencing (MALDI-TDS) delivers N- and C-terminal sequence readout for intact proteins or protein subunits within minutes. Leverage the novel neofleX™ MALDI-TDS workflow for verification of therapeutic antibodies, antigens and other protein expression products regarding sequence, terminal status and modifications and, thereby, enable instant decision making in strain development and production in biopharma or other branches of industry.
During this webinar, you will learn:
- Overview of neofleX technology and its benefits to life sciences applications
- neofleX top-down workflow: Protein sequence verification with shortest time-to-result
- OmniScape™ software: From data to sequencing results with just a few mouse clicks
Who should attend:
- Characterization team leaders in biopharma companies and CROs
- Mass spectrometry core lab managers
- Researchers who are interested in fast protein characterization methods
- Anyone who needs to deliver instant sequence verification for protein expression products
- Anyone who would like to learn about the latest MALDI-TOF/TOF technology
Speakers
Jan Hendrik Kobarg, Ph.D., Product Manager, MALDI-TOF, Bruker Daltonics, Bremen, Germany
Jan Kobarg, Ph.D., is the product manager for the MALDI-TOF instrument portfolio at Bruker. The latest addition to the portfolio is the neofleX™ MALDI-TOF Benchtop instrument.
Arndt Asperger, Ph.D., Senior Applications Scientist, Bruker Daltonics, Bremen, Germany
Arndt is analytical chemist by training and got his Ph.D. from Leipzig University. He joined Bruker in 2002 and has been working in various application related positions with a focus on pharma/biopharma.
For Research Use Only. Not for use in clinical diagnostic procedures.